Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis
- Simon Wandel, research fellow12,
- Peter Jüni, professor and head of division12,
- Britta Tendal, research fellow3,
- Eveline Nüesch, research fellow12,
- Peter M Villiger, director4,
- Nicky J Welton, senior research fellow5,
- Stephan Reichenbach, senior research fellow14,
- Sven Trelle, senior research fellow12
+ Author Affiliations
1Institute of Social and Preventive Medicine, University of Bern, Switzerland
2CTU Bern, Bern University Hospital, Switzerland
3Nordic Cochrane Centre, Righospitalet, Copenhagen, Denmark
4Department of Rheumatology, Clinical Immunology, and Allergology, Bern University Hospital, Switzerland
5Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol, Bristol, United Kingdom
BMJ 2010; 341:c4675
Conclusions Compared with placebo, glucosamine, chondroitin, and their combination do not reduce joint pain or have an impact on narrowing of joint space. Health authorities and health insurers should not cover the costs of these preparations, and new prescriptions to patients who have not received treatment should be discouraged.
Full text: http://www.bmj.com/content/341/bmj.c4675.full
Leave a Reply